Published in J Immunol on December 15, 1993
The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci U S A (1997) 2.36
Tumour necrosis factor-α inhibition can stabilize disease in progressive vitiligo. Br J Dermatol (2015) 1.42
New perspectives on the role of vitiligo in immune responses to melanoma. Oncotarget (2011) 1.15
Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev (2006) 1.12
GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J Immunol (2010) 1.05
Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo. Lipids Health Dis (2004) 0.99
Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigment Cell Melanoma Res (2014) 0.79
Melanoma epidemiology, biology and prognosis. EJC Suppl (2013) 0.78
Transfer of efficient anti-melanocyte T cells from vitiligo donors to melanoma patients as a novel immunotherapeutical strategy. J Autoimmune Dis (2005) 0.76
T-cell reconstitution after thymus xenotransplantation induces hair depigmentation and loss. J Invest Dermatol (2013) 0.75
Extracellular and intracellular melanin in inflammatory middle ear disease. Laryngoscope (2014) 0.75
Synthetic melanin bound to subunit vaccine antigens significantly enhances CD8+ T-cell responses. PLoS One (2017) 0.75
Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation (1994) 6.03
Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun (1985) 4.00
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
Selection of a human T helper type 1-like T cell subset by mycobacteria. J Exp Med (1991) 3.41
The economic burden of lymphatic filariasis in India. Parasitol Today (2000) 3.15
Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells. Nature (1986) 2.59
HLA-linked genetic control of host response to Mycobacterium leprae. Lancet (1976) 2.45
Synovial fluid T cell reactivity against 65 kD heat shock protein of mycobacteria in early chronic arthritis. Lancet (1988) 2.43
Lifestyle and the risk of rheumatoid arthritis: cigarette smoking and alcohol consumption. Ann Rheum Dis (1990) 2.07
Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum (1990) 2.01
Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG. Infect Immun (1988) 2.01
Mapping of lymphatic filariasis in India. Ann Trop Med Parasitol (2000) 2.00
Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci U S A (1998) 1.99
Unusual association of Kikuchi's disease and dengue virus infection evolving into systemic lupus erythematosus. J Indian Med Assoc (2000) 1.96
Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest (1989) 1.74
The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol (1999) 1.73
Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature (1986) 1.69
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol (1999) 1.68
Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol (2001) 1.68
The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. J Invest Dermatol (1987) 1.67
Adhesion molecules on the endothelium and mononuclear cells in human atherosclerotic lesions. Am J Pathol (1992) 1.66
Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J Infect Dis (2003) 1.65
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
T-cell clones from a type-1 diabetes patient respond to insulin secretory granule proteins. Nature (1990) 1.64
Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus. Gut (2007) 1.63
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
[Turning white overnight, is it possible?]. Ned Tijdschr Geneeskd (1993) 1.61
Characterization of cultured tobacco cell lines resistant to ethionine, a methionine analog. Plant Physiol (1984) 1.57
Haematological and coagulation profile in acute falciparum malaria. J Assoc Physicians India (1992) 1.56
Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India. Trop Med Int Health (2001) 1.56
DDT indoor residual spray, still an effective tool to control Anopheles fluviatilis-transmitted Plasmodium falciparum malaria in India. Trop Med Int Health (2005) 1.54
A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects. Trop Med Int Health (2000) 1.50
Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man. J Exp Med (1990) 1.48
Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 1.48
Grafting of venous leg ulcers. An intraindividual comparison between cultured skin equivalents and full-thickness skin punch grafts. J Am Acad Dermatol (1991) 1.45
Quantifying mosquito biting patterns on humans by DNA fingerprinting of bloodmeals. Am J Trop Med Hyg (2001) 1.44
Evidence for an HLA-DR4-associated immune-response gene for Mycobacterium tuberculosis. A clue to the pathogenesis of rheumatoid arthritis? Lancet (1986) 1.43
A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide. Science (1988) 1.42
IgG4 antibodies in Egyptian patients with schistosomiasis. Int Arch Allergy Appl Immunol (1981) 1.40
[Effective removal of certain skin pigment spots (lentigines) using the Q-switched ruby laser]. Ned Tijdschr Geneeskd (1997) 1.39
Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest (2000) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol (1993) 1.35
Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol (1996) 1.35
Value of butyrylthiocholine assay for identification of cholinesterase variants. J Med Genet (1970) 1.34
Pregnancy and the risk of developing rheumatoid arthritis. Arthritis Rheum (1990) 1.33
HLA class II association with rheumatoid arthritis: facts and interpretations. Hum Immunol (2000) 1.32
HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol (1982) 1.30
Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin. Arch Dermatol Res (1989) 1.29
Bancroftian filariasis in Pondicherry, south India: 1. Pre-control epidemiological observations. Epidemiol Infect (1989) 1.29
Genetic control of survival in epidemics. J Immunogenet (1979) 1.28
HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28
Transmission of non-A non-B hepatitis to chimpanzees by factor-IX concentrates after fatal complications in patients with chronic liver disease. Lancet (1979) 1.28
EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect (2000) 1.27
A campaign of "communication for behavioural impact" to improve mass drug administrations against lymphatic filariasis: structure, implementation and impact on people's knowledge and treatment coverage. Ann Trop Med Parasitol (2006) 1.26
T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetes. Lancet (1991) 1.26
Association of the Köbner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris. Arch Dermatol (1999) 1.25
A geostatistical analysis of the geographic distribution of lymphatic filariasis prevalence in southern India. Am J Trop Med Hyg (2002) 1.23
Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis. J Infect Dis (1990) 1.23
HLA association with autoimmune disease: a failure to protect? Rheumatology (Oxford) (2000) 1.22
Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol (1978) 1.21
TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum (2000) 1.20
HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins. Clin Exp Immunol (1983) 1.19
Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol (1993) 1.19
Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients. J Exp Med (1986) 1.18
Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients. J Exp Med (1988) 1.18
Estimation of age-specific rates of acquisition and loss of Wuchereria bancrofti infection. Trans R Soc Trop Med Hyg (1990) 1.18
Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India. Trop Med Int Health (1999) 1.17
Situation analysis in a large urban area of India, prior to launching a programme of mass drug administrations to eliminate lymphatic filariasis. Ann Trop Med Parasitol (2005) 1.17
A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol (1998) 1.16
Multiple origins of the mtDNA 9-bp deletion in populations of South India. Am J Phys Anthropol (1999) 1.16
Subcellular distribution of monoclonal antibody defined epitopes on immunodominant Mycobacterium tuberculosis proteins in the 30-kDa region: identification and localization of 29/33-kDa doublet proteins on mycobacterial cell wall. Scand J Immunol (1991) 1.15
Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis (1986) 1.14
The HA-2 minor histocompatibility antigen is derived from a diallelic gene encoding a novel human class I myosin protein. J Immunol (2001) 1.14
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. J Immunol (1994) 1.14
Functional impairment caused by lymphatic filariasis in rural areas of south India. Trop Med Int Health (1997) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Monoclonal antibody-based therapy as a new treatment strategy in multiple myeloma. Leukemia (2011) 1.13
Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response. J Immunol (2001) 1.13
Nonsurgical repigmentation therapies in vitiligo. Meta-analysis of the literature. Arch Dermatol (1998) 1.13
T-cell receptor gamma delta bearing cells in normal human skin. J Invest Dermatol (1990) 1.13
The identification of CD4+ T cell epitopes with dedicated synthetic peptide libraries. Proc Natl Acad Sci U S A (1997) 1.12
The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Trop Med Int Health (2003) 1.11
HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol (1999) 1.11
HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol (1996) 1.11
Increased intracellular survival of Mycobacterium smegmatis containing the Mycobacterium leprae thioredoxin-thioredoxin reductase gene. Infect Immun (1997) 1.10
Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. J Immunol Methods (1989) 1.10
Diminished ouabain-sensitive, sodium-potassium ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol (1976) 1.10
HLA class II restriction repertoire of antigen-specific T cells. I. The main restriction determinants for antigen presentation are associated with HLA-D/DR and not with DP and DQ. Hum Immunol (1985) 1.10